Unlocking
Human
Potential

Andrew has experience in venture capital, company building, technology development, and neurosurgery. He has served as founder, investor, director, and chairman of many successful companies.

Previously, he was a partner at Flare Capital Partners (formerly known as Foundation Medical Partners) and a principal at Canaan Partners. He was a founder and invented the core technology of Northstar Neuroscience, which went public and was subsequently acquired by St. Jude Medical. He also served as chairman of IntElect Medical, which was acquired by Boston Scientific. Andrew’s investments prior to JAZZ include BridgePoint Medical (acquired by Boston Scientific), Explorys (acquired by IBM), Functional Neuromodulation, and Visiogen (acquired by Abbott).

Prior to venture capital, Andrew was a board-certified neurosurgeon and served as clinical assistant professor of neurosurgery at Yale School of Medicine and New York University School of Medicine. During more than a decade in the healthcare profession, he published more than 50 medical articles and was co-editor of a book about cerebrovascular surgery. His scientific work has been presented at many international conferences and he holds numerous patents for his inventions. He has served on innovation advisory boards at Yale University, Cleveland Clinic, and Cornell University. Andrew earned his MD from Weill Cornell Medicine and his MBA from the University of Pittsburgh after studying neuroscience at Cornell (AB) and Oxford University.

Andrew serves on the boards of several technology, health, consumer, and enterprise companies in the JAZZ portfolio, including AllStripes, Blue Note Therapeutics, Cadence Neuroscience, Embodied, Magnus Medical, Mahana Therapeutics, Thrive Global, Woebot, Yumi, and Zus.

John Harris is a seasoned investor, entrepreneur, executive, and corporate director with three decades of experience starting, developing, and directing early-stage life sciences and technology companies.

John’s board positions include Foresight Mental Health, Cadence Neuroscience, BlueNote Therapeutics, and HerMD. John is an empathetic, hands-on director who brings expertise in strategic analysis, leadership, creativity, concept development, product development, marketing, and finance.

Prior to JAZZ, John was the founder, president, and CEO of NeuroVista, a Seattle-based medical device company pioneering new technologies for the management and treatment of epilepsy. John was also a founder of Northstar Neuroscience, which went public in 2006 and was subsequently acquired by St. Jude Medical. Previous to that, John was a founder of Heartstream, a company that revolutionized the treatment of sudden cardiac arrest with uniquely designed external defibrillators that remain the global market leader and can be found in airports, sports arenas, public buildings, and many other locations. Heartstream went public in 1996 and was subsequently acquired by Hewlett-Packard.

John holds an engineering degree from Stanford, and an M.B.A. from Northwestern. He is passionate about fly-fishing and the outdoors, and lives with his wife in Medina, Washington.

Zack is an entrepreneur and futurist who has deep insight into how emerging technologies impact industry and human society. He is a proactive board member and investor across a broad array of technology and health-related markets and enjoys helping innovators achieve their visions.

Before JAZZ, Zack built several companies focused on connecting industries including a global conference ecosystem that enabled thousands of startups to tap into new sources of capital. Needing to share his vision for the next 50 years, he wrote the global best-selling book, The Neuro Revolution: How Brain Science Is Changing Our World.

Zack has degrees in evolutionary biology and environmental science as well as a masters degree in economic geography all from UCLA. He sits on the boards of multiple consumer, enterprise and health-related companies across the JAZZ portfolio including: AppliedVR, JobGet, Swing Therapeutics and Pinpoint Predictive.

John is a proven leader in consumer technology and digital media with a career focused on building, scaling and running high-growth companies of all sizes, from initial seed through to late-stage operation. He possesses a deep understanding of building brands, creating innovative experiences and leveraging new and emerging platforms.

Prior to JAZZ, John held senior operating roles in a wide array of technology companies in both the consumer and enterprise sectors. And in a distant past long forgotten, he earned a degree in engineering from Yale.

John sits on the boards of several companies in the JAZZ portfolio, including Outside, FormBio, and Sounding Board.

John is a seasoned investor, focusing on companies across frontier technology, enterprise software, robotics, healthcare, and artificial intelligence. He gravitates towards startups that are using science and technology to break down barriers to productivity growth and enable a better future for the largest number of people.

Prior to JAZZ, John was at Osage University Partners (OUP) and Lux Capital, where he focused on building and investing in companies at the intersection of science and deep technology. He brings extensive expertise in understanding nascent technologies and how they translate into product.

John’s prior investments and board roles include Algorithmia (acq. DataRobot), Body Labs (acq. AMZN), Corelight, Clarifai, Elementary ML, Embodied Robotics, Guardant Health (NYSE: GH), Kymeta, Menlo Security, SiFive, and Streetlight Data.

John holds a BS in Biology from Cornell University. John sits on the boards of several companies in the JAZZ portfolio, including Embodied, Rarebase, Oma Fertility, and Zeitworks.

Justin is an experienced leader in the alternative investment space, where he has focused his time building, scaling, and leading differentiated investment platforms in both public and private markets. Throughout his career, he has emphasized developing genuine, long-term relationships across the investment, media, and sports ecosystems. At JAZZ, Justin leads Capital Formation & Investor Relations, in addition to developing creative ways to expand the JAZZ platform and network.

Prior to JAZZ, Justin spent nearly a decade at TPG, a $150B global alternative investment firm. While at TPG, Justin held various senior leadership roles, including Partner & Head of Fundraising for TPG Public Equity Partners. He also co-founded TPG NEXT, a platform focused on investing in diverse entrepreneurs and investors. Justin helped lead TPG NEXT’s strategic investments in VamosVentures, LandSpire Group, and Harlem Capital.

Prior to TPG, Justin spent several years at Goldman Sachs and Lehman Brothers, where he started his career in Investment Banking.

Justin graduated from Columbia University with a B.A. in History and was a member of Columbia’s Division I-AA Football team for four years. In his final season at Columbia, Justin was an Arthur Ashe Sports Scholar Award Winner, and was also named to the inaugural National Football Foundation Honor Society.

Justin is an avid boxer and runner, but his true passion is spending his free time with his wife and two children.

Sharon is a wellness and healthy aging champion with deep experience in finance, planning and operations that she deploys as a growth and operations strategist for healthcare and health tech startups.

After leading finance and development functions and multi-national teams at KFC, Gap, and Electronic Arts, she joined One Medical Group, which went public in 2020 and is now owned by Amazon, as President. After overseeing the clinic’s growth beyond San Francisco to NYC, Washington, Boston and Chicago, Sharon served as COO of The Plant Café Organic, championing food as medicine, and President and COO of Hawthorne Effect, which is transforming how clinical trials are conducted. Most recently, she led Stop the Spread, a COVID-19 response nonprofit formed to catalyze the private sector’s response to the pandemic with support from Impact Assets and Google.org.

Sharon holds an MBA in Finance from Northwestern University and a BA in Economics from Smith College.

As a Venture Partner at JAZZ, Chris offers deep expertise in the design and development of compelling products, services and communications, and in the leadership of high-performing interdisciplinary teams. Chris advises portfolio companies on human-centered design, inspires them to create engaging user experiences, and helps craft narratives that resonate with the stakeholders that matter most to their success.

Chris is currently an adjunct professor at Stanford University, where he teaches a range of innovation-related courses (in both the School of Engineering and the Graduate School of Business), is a founding faculty member of its renowned “d.school”, and previously earned degrees in engineering, product design, and business.

From 2016 to 2022, Chris was the CEO and Executive Director of the Exploratorium, SF’s pioneering museum of science, art and human perception. Prior to that, he was a senior partner at IDEO, collaboratively designing countless innovative products and co-leading the firm’s Consumer Experience Design practice. Chris enjoyed early entrepreneurial success as an independent inventor and has also served on Fortune 500 public company boards. He relishes opportunities to draw on his diverse experience to help JAZZ portfolio companies get unstuck, shift perspective, and make creative efforts that have meaningful strategic impact.

Jia is interested in how AI will make positive impact on everyday life. She is an entrepreneur who is excited about bringing Generative AI to real-world applications. Most recently she is the Co-Founder, Chief AI Officer and President of LiveX AI, which aims to transform the way we live towards a smart, sustainable, and an enjoyable home environment.

Previously, she was the Founding Global Head of R&D at Google Cloud AI. At Google, she oversaw the development of the full stack of AI products on Google Cloud to power solutions for diverse industries. Before joining Google, Jia was the Head of Research at Snap, leading the AI/AR innovation effort.

With the passion to make more impact to our everyday life, she has also had a distinguished career building and advising companies with award-winning platforms to solve today’s greatest challenges across many industries and disciplines. She has served as Mentor and Professor-in-Residence at StartX, advising founders/companies from Stanford alumni. She is the Co-Founder and Chairperson of HealthUnity Corporation, a volunteer-based nonprofit organization. She served at Accenture as a part-time Chief AI Fellow for the Generative AI strategy. She also serves as an advisor to the United Nations Children’s Fund (UNICEF). She is a board member of the Children’s Discovery Museum of San Jose.  She was elected as IEEE Fellow for Leadership in Large Scale AI. She co-taught the inaugural course of Generative AI and Medicine at Stanford University, where she has served multiple roles, including Advisory Board Committee to Nourish, Chief AI Fellow, Fellow of RWE for Sleep Health, and has also served as Adjunct Professor at the Stanford School of Medicine.

She received her Ph.D. degree from the Computer Science Department at Stanford University.

Chit-Kwan (CK) brings to JAZZ deeply technical expertise, drawn from over twenty years in academic and industry settings, spanning machine learning, computer architecture, distributed computing, cyber-physical systems, wireless networking, software engineering, and healthcare tech. Trained as a computer scientist, with dozens of peer-reviewed publications and patents, he has a passion for research commercialization and most enjoys building teams that turn lab innovations into useful products.

Currently, CK is the founder and CEO of Revelata, Inc., a natural language processing startup serving the finance industry. Previously, CK was at Intel Corporation, where he was responsible for the first API and compiler for Loihi, Intel’s (non-von Neumann) neuromorphic research chip, and where he subsequently led the Smart Computing Architecture Team in its effort to improve CPU performance by directly incorporating machine learning into Intel microarchitecture. Earlier in his career, CK worked on advanced protocols for drone and satellite networks at Harvard and MIT Lincoln Lab, and was a software engineer for many years at various startups.

CK holds an A.B. in Biochemical Sciences, and S.M., and Ph.D. degrees in Computer Science, all from Harvard University.

Ido has long and successful experience in developing and investing in consumer and digital brands. He has extensive networks in the start-up communities of Silicon Valley and Australasia.

Ido is the co-founder at Yoobi, a school supplies company that engages kids through bright colours, cool designs and, most importantly, cause: Yoobi has provided free school supplies to over 5.5 million kids. He is also a co-founder of Beach House Group – a global consumer product house.

Ido is a non-executive director of Vestergaard, Southern Cross Austereo, Yumi and The Lux Group. Previously Ido was non-executive director of Spark New Zealand Limited (Formerly Telecom NZ) from 2012-2020.

He sits on other corporate and advisory boards, including as an emeritus member of the United Nations Foundation Global Entrepreneur Council.

Adam currently serves as a Venture Partner at JAZZ where he advises the firm and its portfolio companies on scientific, research and technological operations. Adam is lab director and professor of neurology, physiology and psychiatry at University of California, San Francisco.

He received his M.D. and Ph.D. degrees in Neuroscience through the NIH-sponsored Medical Scientist Training Program at the Mount Sinai School of Medicine in New York. He went on to complete an internship in internal medicine and residency in neurology at the University of Pennsylvania. Following residency, Dr. Gazzaley was awarded a research fellowship at University of California, Berkeley where he worked with Dr. Mark D’Esposito and Dr. Robert Knight. The research involved studying memory and attention in humans and the changes that occur with normal aging using functional magnetic resonance imaging (fMRI) and electroencephalography (EEG). During this time, he also completed a clinical fellowship in cognitive neurology at the Memory and Aging Center, under the direction of Dr. Bruce Miller, and became board-certified in neurology.

Adam is the founding director of the Neuroscience Imaging Center at the University of California, San Francisco; an Associate Professor in Neurology, Physiology and Psychiatry; and Principal Investigator of a cognitive neuroscience laboratory. His laboratory studies neural mechanisms of perception, attention and memory, with an emphasis on the impact of distraction and multitasking on these abilities. His unique research approach utilizes a powerful combination of human neurophysiological tools, including fMRI, EEG and transcranial stimulation (TES). Through this research, Adam has been able to expand our understanding of alterations in the aging brain that lead to cognitive decline. His most recent studies explore how we may enhance our cognitive abilities via engagement with custom-designed video games, neurofeedback and TES.

Adam has authored over 100 scientific articles, delivered almost 400 presentations globally, including TED and TEDMED, and his research and perspectives have been consistently profiled in national and international media outlets that include The New York Times, New Yorker, Wired, NBC Nightly News, and others. Recently Adam wrote and hosted the nationally televised, PBS-sponsored special “The Distracted Mind with Dr. Adam Gazzaley.”

Sujude Dalieh is an investor at JAZZ where she invests at the intersection of cultural trends and deep science.

Prior to JAZZ, Sujude supported investments across fronteir tech, workforce solutions, and health innovations at Lux Capital and K50 Ventures. Sujude started her career off in the computational sciences and is a Berkeley-trained scientist. She was a member of the Somorjai Group, a surface chemistry research lab at the Lawrence Berkeley National Laboratory, and she subsequently led the integration of the Jupyter Project at the Berkeley Institute of Data Science across over 50 clients. She pivoted to digital product strategy, where she built an array of community-forward health initiatives at Hopelab and YTH.

Sujude holds an MEng in Product Design Engineering from Stanford University and a BS in Chemistry from UC Berkeley and currently guest lectures at both institutions. Sujude currently sits on the boards of Mercaso and JobGet and is active in the MENA-affiliated startup world as a member of TechWadi.

Matt is an experienced entrepreneur with a passion for health and human performance.

Prior to joining JAZZ, Matt was the Founder and CEO of Momentous, a performance nutrition company that he started at 18 and dropped out of Harvard to build. He led the company through several rounds of venture funding to become a trusted consumer brand and the leading supplier of supplements and nutrition products for professional and collegiate sports teams in the US. Momentous was acquired by Amp Human in 2021, after which Matt shifted to the role of Chief Product Officer to help manage the company’s transition.

Outside of JAZZ, Matt is an avid endurance athlete, an active angel investor and a minority owner in Leeds United Football Club.

Stone Connell is the Chief Financial Officer for JAZZ Venture Partners where he leads the finance, accounting, and operational functions of the firm. Prior to joining JAZZ, Stone served as the Director of Finance for Biomatics Capital, a life sciences venture capital firm, where he managed the financial, reporting, and administrative activities.

Previously, Stone was an engagement manager with the fund administrator, Standish Management, serving clients across the private equity industry. He began his career with PwC as an auditor within the asset management line of service. At PwC he provided audit and consulting services to clients ranging from large hedge funds to local private equity managers in the Seattle market.

Stone is a Certified Public Accountant and earned his B.A. in Business Administration (Accounting emphasis) as well as his Masters in Accountancy from the University of Washington – Seattle.

Outside of work, you’ll find Stone outdoors with his family hiking, skiing, running or exploring outdoors. He is also an avid sports fan and always enjoys going to a local game.

Diana Stoner serves as Director of Finance and Operations for JAZZ Venture Partners, where she supports the finance, accounting, and operational functions of the firm.

Prior to joining JAZZ, Diana spent her career in Accounting at alternative investment firm HBK Capital Management in Dallas, Texas. Diana is a Certified Public Accountant and earned her B.S. in Accounting and M.S. in Management from Texas A&M University.